For Medicare beneficiaries with acute ischemic stroke, the NIH Stroke Scale provided substantial prognostic information regarding 30-day mortality risk, according to recent study results.

Professor of neurology at UCLA and a co-principal investigator, Dr. Steven Cramer, MD affirms, “Reaching Phase 3 in a clinical trial of this scale is a hard-won milestone that has been twelve ...